1. Home
  2. NEE vs NVS Comparison

NEE vs NVS Comparison

Compare NEE & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextEra Energy Inc.

NEE

NextEra Energy Inc.

N/A

Current Price

$85.11

Market Cap

172.3B

Sector

Utilities

ML Signal

N/A

Logo Novartis AG

NVS

Novartis AG

N/A

Current Price

$160.40

Market Cap

311.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEE
NVS
Founded
1925
1895
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.3B
311.6B
IPO Year
2003
2001

Fundamental Metrics

Financial Performance
Metric
NEE
NVS
Price
$85.11
$160.40
Analyst Decision
Buy
Hold
Analyst Count
22
11
Target Price
$94.00
★ $157.10
AVG Volume (30 Days)
★ 12.9M
2.1M
Earning Date
10-21-2026
10-27-2026
Dividend Yield
★ 2.92%
1.92%
EPS Growth
N/A
★ N/A
EPS
★ 1.04
N/A
Revenue
★ $14,256,000,000.00
N/A
Revenue This Year
$11.60
$1.92
Revenue Next Year
$11.92
$6.84
P/E Ratio
$82.18
★ $23.13
Revenue Growth
N/A
N/A
52 Week Low
$74.41
$123.24
52 Week High
$98.75
$170.46

Technical Indicators

Market Signals
Indicator
NEE
NVS
Relative Strength Index (RSI) 56.76 58.47
Support Level $83.48 $148.74
Resistance Level $87.52 $160.57
Average True Range (ATR) 1.47 2.59
MACD 0.03 -0.30
Stochastic Oscillator 44.60 54.01

Price Performance

Historical Comparison
NEE
NVS

About NEE NextEra Energy Inc.

NextEra Energy's regulated utility, Florida Power & Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with nearly 40 GW of generation capacity, including natural gas, nuclear, wind, and solar.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: